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Abstract 
Background: Raised blood pressure (BP) remains an important risk factor for cardiovascular diseases such as stroke. 
Adherence to therapeutic recommendations especially antihypertensive drugs is important in BP control. The aim 
of the study was to assess the stroke risk factors and levels of adherence among hypertensive patients with stroke in 
Kampala Uganda.
Methods: In a cross-sectional study we describe 112 hypertensive subjects with stroke from two Kampala city hospi-
tals. A standardized pre-tested questionnaire was used to collect medical history, clinical details, radiological findings 
and laboratory data.
Results: A total of 112 hypertensive subjects with stroke were enrolled between May 2013 and April 2014. The 
median ages were 63.5 years (52.5–75.0) for the cases. Seventy percent (78/112) of the study participants had 
ischemic strokes. Only 17 % were adherent to anti-hypertensive medications. The main cause of non-adherence 
appears to be lack of knowledge.
Conclusions: Poor adherence of anti-hypertensive medications among hypertensive patients remains a big chal-
lenge in our setting. This has been attributed to lack of adequate knowledge and cost of the prescribed drugs. There 
is therefore an urgent need to promptly diagnose and educate hypertensive patients with emphasis on adherence to 
anti hypertensive drugs.
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Background
Stroke remains a global health problem with an esti-
mated 15 million people worldwide suffering from 
non-fatal strokes yearly [1]. About 5.5 million people 
are estimated to have died from stroke in 2001 while 
a third of these developed disabilities [1–3]. Stroke is 
also the leading cause of functional impairment, with 
nearly 20  % of stroke survivors requiring institutional 
care after 3 months post stroke and 15–30 % remaining 
permanently disabled [4]. The incidence and mortal-
ity of stroke varies greatly among different populations 
and geographic locations. Stroke incidence has declined 
considerably in several western countries due to bet-
ter preventive measures for hypertension. In contrast, 
stroke rates are increasing in sub-Saharan Africa, espe-
cially Uganda, where stroke awareness and therapeutic 
interventions are very limited [3]. The inter-stroke study 
reported important risk factors for stroke as history of 
hypertension, current smoking; waist-to-hip ratio; regu-
lar physical activity; diabetes mellitus; alcohol intake 
for more than 30 drinks per month or binge drinking; 
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psychosocial stress; depression; cardiac causes; and 
a high ratio of apolipoproteins B to A1. These risk fac-
tors collectively accounted for 90.3 % (85.3–93.7) for all 
strokes [5]. Control of these major cardiovascular risk 
factors, using medical treatment and lifestyle changes has 
been advocated for so as to reduce the risk of stroke [6]. 
There is limited data regarding the stroke risk factors in 
sub-Saharan Africa. A major precipitant to stroke in sub-
Saharan Africa is unrecognized and untreated hyperten-
sion. One study in Nigeria [7] looked at factors associated 
with stroke among hypertensive patients in Africa and 
found that 13.2 % of the stroke patients were first diag-
nosed as hypertensive at presentation with stroke.
Information on stroke risk factors among hypertensive 
patients will form a basis for designing specific stroke 
prevention strategies and treatment guidelines in our set-
ting. This will be a key milestone in mitigating the rising 
incidence of stroke and stroke recurrences in Uganda. 
The overall objective of this study was to assess stroke 
risk factors and anti-hypertensive drug adherence among 
hypertensive patients admitted with stroke in two city 
hospitals in Kampala, Uganda.
Methods
In a cross-sectional study design we consecutively 
recruited known hypertensive stroke subjects in two 
urban teaching hospitals in Kampala, Uganda.
The study was carried out in two hospitals, St Raph-
ael of St Francis Nsambya and Mulago national teach-
ing and referral hospital. Nsambya hospital is located 
4.8 km south west of Kampala and is a tertiary hospital 
with a bed capacity of 361 beds and receives 8–10 stroke 
patients per month. Mulago is the National referral hos-
pital for Uganda and also the teaching hospital for Mak-
erere University College of Health Sciences. Mulago 
hospital has a 50 bed neurology unit. It receives over 30 
stroke patients in a month. Both hospitals have resident 
neurologists with Computerized Tomography (CT) scan 
services. The study inclusion criteria were; adult hyper-
tensive patients >18 years, with a radiological confirmed 
diagnosis of stroke on a CT scan and written informed 
consent. We excluded patients with Transient Ischemic 
attack (TIA), traumatic hemorrhagic stroke or patients 
with brain space occupying lesions such as tumors or 
metastases.
Over a period of 1  year (May 2013–April 2014), we 
consecutively enrolled hypertensive adults admitted with 
a diagnosis of an acute stroke and consented to partici-
pate in the study. Stroke was defined as a neurological 
deficit attributed to an acute focal injury of the central 
nervous system (CNS) by a vascular cause, including 
cerebral infarction, intracerebral hemorrhage (ICH) [8]. 
Ischemic stroke was defined as an episode of neurological 
dysfunction caused by focal cerebral, spinal, or retinal 
infarction while hemorrhagic stroke was defined as rap-
idly developing clinical signs of neurological dysfunction 
attributable to a focal collection of blood within the brain 
parenchyma or ventricular system that is not caused by 
trauma [8]. The strokes were confirmed by neurological 
exam demonstrating neurological deficits attributed to 
the involved area. On a non contrast CT a clearly vis-
ible hypo attenuated area represented ischemic stroke [9] 
while a hyper dense region when compared with the sur-
rounding brain tissue showed a hemorrhagic stroke [10].
A general clinical examination, vital signs assessment 
including pulse, blood pressure (BP) and complete neu-
rological examination were performed. The neurological 
exam included mental state exam, cranial nerve exam, 
muscle power, reflexes, tone and sensation. Gait was not 
performed among these participants. Peripheral blood 
was collected for fasting lipid profile, renal function tests, 
liver function tests, serum electrolytes and fasting blood 
glucose, complete blood count (CBC) and erythrocyte 
sedimentation rate (ESR). The level of blood sugar con-
trol was assessed by reviewing the medical record and 
determining the glycosylated haemoglobin levels at the 
time of recruitment into the study. Levels of glycosylated 
haemoglobin above 8  % were considered poor control 
while those below 7  % were considered good control. 
Patients were considered to have dyslipidemia if, they 
had total cholesterol ≥240  mg/dl, low-density lipopro-
tein cholesterol ≥160  mg/dl, <40  mg/dl) high-density 
lipoprotein cholesterol or self-reported prior diagnosis of 
high cholesterol and current use of cholesterol-lowering 
medications with supporting medical documents [11]. 
Appropriate referrals were done for study participants 
requiring specialized medical attention.
Using a standardized pre-tested questionnaire, demo-
graphic data and life styles history such as smoking, 
alcohol consumption and level of physical activity were 
obtained. We assessed for concurrent medical co-mor-
bidities relevant to stroke such diabetes mellitus, Human 
Immunodeficiency deficiency (HIV), cardiac diseases 
and medication adherence. We also assessed smoking 
history (in pack years), level of moderate exercise based 
(walking, cycling, or gardening) and level of strenuous 
exercise (jogging, football, and vigorous swimming) for 
4 h or more per week [7].
The Alcohol Use Disorders Identification Test (AUDIT) 
was used to categorize alcohol consumption among the 
study participants. The AUDIT categorizes alcohol use 
into excessive drinking, harmful drinking and alcohol 
dependence. It has a total of ten questions, three ques-
tions on alcohol consumption, three questions on drink-
ing behaviors and dependence and four questions on the 
consequences or problems related to drinking. There 
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are different scoring scales allocated to the questions. A 
score of less than four is categorized as low risk, 8–15 as 
risky or hazardous drinking, 16–19 as high risk or harm-
ful and while those with scores of 20 or more are catego-
rized as being alcohol dependent [12].
The Morisky 8-item Medication Adherence Question-
naire was used to assess the level of adherence to anti 
hypertensive medication by the participants. The ques-
tionnaire has a total of eight questions with a score of one 
allocated to each question. Participants are categorized as 
having high adherence if they score 0, 1 or 2 as medium 
adherence while those above two are categorized as hav-
ing low adherence [13].
Blood pressure
BP and heart rate were measured with an Omron auto-
mated sphygmomanometer model HEM-907 whose 
accuracy has been validated [14]. The admission systolic 
and diastolic BP were recorded among all study partici-
pants. Three readings were taken 3  min apart and the 
closest two were used to determine the averages which 
were recorded as the BP of the patient.
The standard of care provides for CT scan for all stroke 
patients, and then further work up for ECG and ECHO/
carotid Doppler/CT angiography requires payments 
for these tests. All study subjects had an ECG done and 
those with irregular heart rates received further testing 
with Echocardiography.
Data management and analysis
Data were entered into EPI-DATA version 2.1 (http://www.
epidata.software.informer.com) and analysed using Stata 
12.0 (Stata Corporation, College Station, Texas, USA). 
Summaries for frequencies, percentages, medians and 
interquartile ranges were presented in tables and figures.
Ethical consideration and informed consent
Written informed consent was obtained from all study 
participants or next of kin/legal representative for indi-
viduals unable to complete written forms. Information 
about the study, its potential risks and benefits to the 
patients were elaborated to the patients/relatives in sim-
ple and concise language. Approval for conducting the 
study in the two hospitals was provided from the Depart-
ment of Internal Medicine Mother Kevin Postgraduate 
Medical School and the School of Medicine, Research 
and Ethics Committee of Makerere University College of 
Health Sciences (Ref no—2013-147).
Results
Demographic characteristics of participants
A total of 336 stroke subjects were admitted during 
the study period with 62 and 268 from Nsambya and 
Mulago respectively. Out of these, 112 known hyperten-
sive patients with stroke who provided written informed 
consent were then recruited during the study period, as 
illustrated in Table  1. The median age (IQR) was 63.5 
(52.5–75.0) years. Nearly, 19  % (21/112) of the study 
subjects were less than 50 years. Nearly half of the study 
subjects were aged between 51 and 70 years. About 59 % 
(66/112) of the study participants were female. Eight per-
cent of the study participants were single, 72 % were mar-
ried, none cohabiting, 6 % divorced and 13 % widowed. 
Nearly half of the study participants lived within urban 
centers. The mean (±SD) systolic and diastolic admission 
BP in mmHg were 166 ± 33.2 and 98 ± 26.2 respectively.
Type and location of strokes among the study subjects
About 70 % (78/112) of the study subjects had ischemic 
stroke while 30  % (34/112) had a hemorrhagic stroke. 
Nearly, 92  % of the ischemic stroke occurred in the 
Table 1 Demographic characteristics of study participants 
(n= 112)
Demographic characteristics
Age in years, median (IQR) 63.5 (52.5–75.0)
Age categories
 ≤40 years 7 (6.3)
 41–50 years 14 (12.5)
 51–60 years 26 (23.2)
 61–70 years 26 (23.2)
 71–80 years 24 (21.4)
 >80 years 15 (13.4)
Gender, n (%)
 Male 46 (41.1)
Marital status, n (%)
 Single 9 (8.0)
 Married 81 (72.3)
 Cohabiting 0 (0.0)
 Divorced 7 (6.3)
 Widowed 15 (13.4)
Address, n (%)
 Rural 49 (43.7)
 Urban 63 (56.3)
Occupation, n (%)
 Peasant farmer 51 (45.5)
 Gainful employment 48 (42.9)
 Retired or unemployed 13 (11.6)
Education level, n (%)
 None 32 (28.6)
 1–7 years in school 52 (46.4)
 8–13 years in school 6 (5.4)
 >13 years in school 22 (19.6)
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anterior cerebral circulation vessels compared to 8  % 
which occurred in the posterior circulation vessels.
Hypertension care
The median years (IQR) for the duration of BP since 
hypertension diagnosis to the stroke incidents among 
the study subjects was 4.5 (2–10)  years. Only 45 sub-
jects (40.2  %) were regularly attending routine care for 
their hypertension control. More than half of the partici-
pants (64/112) had never sought medical attention nor 
had their BP reviewed again in the past 12  months after 
being diagnosed with high BP. Among those who regu-
larly attended medical care for their hypertension, 29  % 
attended monthly, 5  % every two months and 9  % quar-
terly. Nearly 53 %, (59/112) were not currently on regular 
anti-hypertensive therapy. The most commonly prescribed 
therapies were calcium channel blockers (Amlodipine and 
Nifedipine) while the least prescribed was methyldopa at 
0.9 %. More than half of the study subjects were receiving 
dual anti-hypertensive therapy, while 14 % were receiving 
three or more drugs for BP control. Only 2.6 % (3/112) of 
the study subjects were receiving lipid lowering therapy. 
However, 33  % (37/112) reported that they were taking 
concomitant herbal medication. Fifty-three percent had a 
family history of hypertension. Forty-two percent reported 
that the biggest challenge they faced was cost of the pre-
scribed drugs, while 40 % had no challenges. Among the 
study participants 21  % (24/112) were diabetic, of whom 
over 95 % had a good level of blood sugar control (Table 2).
Clinical characteristics, life‑styles factors and anti 
hypertensive drug adherence
Eight study participants (7  %) had coexisting associ-
ated heart disease with atrial fibrillation contributing 
to 63 % (5/8) followed by ischemic heart disease (37 %). 
Nearly 4  % of the stroke cases (4/112) had coexisting 
HIV infection and three of these were already receiving 
anti-retroviral therapy (ART). Thirteen percent (14/112) 
had a previous stroke. Eight percent had a positive fam-
ily history of stroke among their first degree relatives. 
Seventeen percent had a current history of alcohol con-
sumption, more than half were considered low risk using 
the AUDIT score for alcohol. Only 32.1 % were involved 
in routine exercise (Tables 3, 4). Only 17 % of the study 
participants were highly adherent to their prescribed 
anti-hypertensive treatment compared to 77 % who were 
poorly adherent according to the Morisky drug scores 
(Fig.  1). The leading reasons for poor drug adherence 
were lack of knowledge of the chronicity of hyperten-
sion (73 %), cost of the drugs (63 %) and access to health 
care provision (15 %). However, 19 % of the study partici-
pants were not able to provide a reason for the poor drug 
adherence (Figs. 1, 2).
Discussion
This cross-sectional descriptive study of hypertensive 
subjects with stroke underscores the magnitude of the 
lack of awareness of hypertension and the suboptimal 
medication adherence in urban Ugandans. Nearly two-
thirds of the study participants were poorly adhering to 
the prescribed anti-hypertensive medications following 
the diagnosis of hypertension.
Table 2 Distribution of  study participants by  blood pres-
sure variables (n = 112)
Blood pressure variable n (%)
Duration since diagnosed with blood pressure (years),  
Median (IQR)
4.5 (2–10)
Routine care, n (%)
 Yes 45 (40.2)
Frequency of review, n (%)
 Not reviewed 64 (57.1)
 Monthly 32 (28.6)
 Every 2 months 6 (5.4)
 Every 3 months 10 (8.9)
Current treatment for hypertension, n (%)
 Yes 53 (47.3)
Drugs participant uses for blood pressure, n (%)
 Calcium channel blockers 43 (39.1)
 Diuretics 14 (12.7)
 Β-blockers 15 (13.6)
 ACEIs/ARBs 37 (33.6)
 Alpha–adrenergic agonist (methyldopa) 1 (1)
Drug therapy, n (%)
 Mono-therapy 16 (28.1)
 Duo-therapy 33 (57.9)
 Multi-therapy 8 (14.0)
Lipid lowering therapy, n (%)
 Yes 3 (2.6)
Herbal medication, n (%)
 Yes 37 (33.0)
Family history of hypertension, n (%)
 Yes 59 (52.7)
Challenges experienced on drugs, n (%)
 Cost 47 (42.3)
 Access 9 (8.1)
 Side effects 4 (3.6)
 Pill load 3 (2.7)
 None 45 (40.5)
Previous diagnosis of diabetes mellitus, n (%)
 Yes 24 (21.4)
Currently on medication for diabetes, n (%)
 Yes 21 (87.5)
Level of control for sugar, n (%)
 Good 20 (95.2)
 Poor 1 (4.8)
Page 5 of 8Mugwano et al. BMC Res Notes  (2016) 9:3 
Hypertension still remains a major independent fac-
tor of morbidity and mortality [15]. With the raising lev-
els of non-communicable diseases in sub-Saharan Africa 
the morbidity and mortality from cerebro-vascular acci-
dents is estimated to increase [3]. Correct and prompt 
institution of BP reduction measures has shown benefit 
in reducing the incidence of stroke [16–18]. The lack of 
adhering to the prescribed medications for hypertension 
and stroke awareness within our communities might be 
increasing the high rates of strokes in Uganda. More than 
half of participants were not regularly attending medi-
cal care since being diagnosed with high BP. This would 
have predisposes the higher BP levels, inadequate control 
and lack of continuous health education subsequently 
increasing the risk of strokes. Up-scaling of hypertension 
awareness campaigns and health education is therefore 
urgently needed to stem this trend.
There are differences in age among people who suf-
fer strokes within the sub-Saharan region compared to 
those in developed countries. In our study, 42  % of the 
study participants were less than 60  years. Studies have 
reported that stroke occurs at an earlier mean age of 
57 years in sub-Saharan Africa compared to 66.0 years in 
developed countries, with those ≤45  years constituting 
24 % in Africa and 8 % in developed countries [19, 20].
Antihypertensive medications are the mainstay of treat-
ment for essential hypertension [21, 22]. Earlier studies 
have demonstrated that there is a significant relationship 
between lower medication adherence and first stroke 
among hypertensive patients [23–27]. In our study, 77 % 
of the study participants were poorly adhering to medica-
tion prior to stroke. Medication adherence is associated 
with improved BP control and with reductions in stroke 
among those at risk for stroke [24, 25]. Some of the study 
subjects were using concomitant herbal medications. 
Whereas some herbal medications have been reported 
Table 3 History of  clinical characteristics and  life style 
among study participants (N = 112)
History of heart disease, n (%) Yes 8 (7.1)
Previous diagnosis of HIV, n (%) Yes 4 (3.6)
Previous history of stroke, n (%) Yes 14 (12.5)
Family history of stroke, n (%) Yes 9 (8.0)
Warfarin therapy, n (%) Yes 3 (2.7)
Current history of smoking, n (%) Yes 2 (1.8)
Current history of alcohol consumption, n (%) Yes 19 (17.0)
Previous history of smoking, n (%) Yes 3 (2.7)
Pack years, median (IQR) 10 (9–10)
Regular exercise, n (%) Yes 36 (32.1)
Table 4 Distribution of study participants by their choles-
terol levels (N = 112)
Total cholesterol, n (%)
<200 (normal) 54 (60.0)
 200–239 (border line high) 20 (22.2)
 ≥240 (high) 16 (17.8)
HDL cholesterol, n (%)
 >40 (desirable) 61 (67.8)
 ≤40 (lower than desired) 29 (32.2)
LDL cholesterol, n (%)
 <100 (optimal) 28 (31.1)
 100–129 (near optimal) 24 (26.7)
 130–159 (border line high) 23 (25.6)
 160–189 (high) 9 (10.0)
 ≥190 (very high) 6 (6.7)
Fasting triglycerides, n (%)
 <150 (normal) 44 (80.0)
 150–199 (border line high) 5 (9.1)
 200–499 (high) 5 (9.1)

















Morisky drug score 
Drug adherence 
Fig. 1 Shows the anti-hypertensive medication adherence according to the Morisky drug score
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to have hypotensive effects, some might interfere with 
hypertensive drug bioavailability and efficacy [28]. Rec-
ommending adherence to the correct drugs and dosage 
still remains a challenge in our settings.
Barriers to anti-hypertensive medication adherence 
are multi-factorial, including complex medication regi-
mens, excessive dosing frequency or pill burden, personal 
behavioral factors, trust communications of the health 
personnel, drug side effects, complications of treatment 
and other co-existing medical conditions [29, 30]. Rea-
sons reported by stroke survivors in other studies include; 
lack of adequate knowledge, cost of the medications, drug 
access, drug side effects and pill burden [31, 32]. The role 
of the health workers however, was not explored in this 
study. Health care workers need to ensure that patients 
understand their health condition, the importance of 
drug adherence and the implications of non-adherence. 
In Uganda, medications are typically provided for by the 
Ugandan government. However, during periods of drug 
stock-outs patients have to buy their medications out of 
pocket. Some hypertensive participants in our sample 
were poorly adhering due to financial or access reasons.
Overall, our findings suggest the need for increasing 
hypertension awareness and drug adherence in stroke pre-
vention. Preliminary data from Rose et al. suggest that treat-
ment intensification is ultimately the most effective strategy 
to achieve controlled BP regardless of the status of medi-
cation adherence [33, 34]. Setting up easily accessible BP 
measuring sites, and making treatment and support readily 
available, would help mitigate this upcoming scourge.
This study had important limitations including cross-
sectional design and relatively small sample size. Medi-
cation adherence using patient self-reporting may 
introduce recall bias. Self-reported medication adherence 
may also be subject to social desirability bias and may 
lead to misclassification regarding the true prevalence of 
low medication adherence [35]. However adherence rates 
were similar to other studies and the Morisky scale is a 
well validated instrument that has been used for more 
than 25  years. Recent evidence demonstrates its cor-
relation with pharmacy fill/refill data [36, 37]. We were 
also not able to assess the relationships between stroke 
and the co-morbidities such as diabetes mellitus, hyper-
lipidemia, HIV, other cardiovascular diseases, alcohol 
consumption, amphetamine use, cigarette smoking and 
level of physical activity due to the low power. No stroke 
severity scales were used in this study we hence did not 
measure the severity of the strokes in our participants. 
Another setback was absence of vascular imaging to clas-
sify the strokes based on the TOAST criteria, we relied 
on the radiologists reports which is has many setbacks. 
This made it difficult to accurately assess the location of 
strokes especially in the posterior fossa.
In conclusion, not being in routine care for hyperten-
sion and poor adherence to anti hypertensive medica-
tions are important factors among hypertensive patients 
admitted in the two study hospitals in Kampala, Uganda. 
There is an urgent need to raise the level of knowledge 
regarding screening for hypertension and the importance 
of BP control among hypertensive patients in Uganda. 
Increased funding to the Health Sector for the procure-
ment of drugs and other health supplies could reduce the 
financial burden of out of pocket expenses met by hyper-
tensive patients for routine care. There is also need for 
larger studies with a longitudinal design and more focus 
on lifestyle or other risk factors that may influence health 
behaviors and stroke risk.
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Fig. 2 Shows the reasons for low drug adherence among the study participants
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